This is the authors' abstract. We don't add key points for this paper.
The long-term comparative effectiveness and safety of DBS confirm it as a valid option for the treatment of severe refractory OCD.
No takes yet. Share an insight, caveat, or question.
Mar‐Barrutia et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: